CAR-T cells are a type of treatment where a patient’s T cells (a type of immune cell) are modified in the laboratory to bind to cancer cells and destroy them.

Advanced Therapy Medicinal Products are regulated by Regulation (EC) No 1394/2007.

As shown in the latest report published by AseBio, biotech companies continue to remain among the top five positions in terms of R&D investment intensity.